Real-world evaluation of weekly subcutaneous treatment with semaglutide in a cohort of Italian diabetic patients

PURPOSE: Registered trials and real-world evidence (RWE) studies provided evidence on the efficacy of once-weekly (OW) semaglutide on hyperglycaemia and cardiovascular risk factors as add-on or de-novo treatment in type 2 diabetes (T2D). METHODS: In a retrospective analysis of electronic data files...

Descripción completa

Detalles Bibliográficos
Autores principales: Marzullo, P., Daffara, T., Mele, C., Zavattaro, M., Ferrero, A., Caputo, M., Prodam, F., Aimaretti, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270295/
https://www.ncbi.nlm.nih.gov/pubmed/35429298
http://dx.doi.org/10.1007/s40618-022-01799-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270295/
https://www.ncbi.nlm.nih.gov/pubmed/35429298
http://dx.doi.org/10.1007/s40618-022-01799-2

Ejemplares similares